salivary cortisol
Overview
Salivary cortisol is the fraction of the steroid hormone cortisol measured in saliva, and it is widely used as a non-invasive biomarker of hypothalamic-pituitary-adrenal (HPA) axis activity. Because salivary cortisol reflects the biologically active, unbound portion of circulating cortisol, it is commonly used in research and clinical settings to assess stress responses, adrenal function, and endocrine dysregulation.
In biomedical research, salivary cortisol is especially useful for monitoring dynamic changes over time, such as responses to acute stress, surgery, pain, exercise, or endocrine interventions. It is frequently paired with other markers of autonomic or endocrine activity, including salivary alpha-amylase, plasma hormone profiling, and targeted metabolomics, to characterize stress physiology more comprehensively.
Recent Publications Summary
Recent publications have used salivary cortisol as a non-invasive biomarker of stress physiology and treatment response in clinical and experimental settings. In a randomized controlled trial of bright light therapy for depression, salivary cortisol was measured alongside melatonin to assess circadian and mood-related effects; the morning bright light group showed improvement in anhedonia, and changes in anhedonia were correlated with melatonin phase shifts, while cortisol indices were also tracked throughout treatment 41785919Mar. Salivary cortisol was also incorporated into biomarker-focused studies of cortisol detection platforms, including a time-gated fluorescent aptamer sensor designed for continuous monitoring of cortisol in complex biological matrices and a triple-mode SERS-LFIA point-of-care platform for ultrasensitive cortisol detection 42017428Apr42009419Apr.
In peri-implant research, cortisol was quantified in peri-implant crevicular fluid rather than saliva, but the study similarly evaluated stress-related endocrine markers in relation to oral disease severity and psychometric measures 42461416Jul. More broadly, several recent publications addressed adrenal insufficiency, corticosteroid replacement, and cortisol dynamics in critical illness or postoperative settings, including study protocols for hydrocortisone supplementation in CIRCI and prednisolone-induced adrenal insufficiency, as well as analyses of postoperative hyponatremia and pituitary surgery outcomes 42309657Jun42276802Jun42301338Jun42301545Jun. These studies did not report salivary cortisol results, but they reflect the continued clinical relevance of cortisol measurement in endocrine and stress-related disorders 42309657Jun42276802Jun42301338Jun42301545Jun.
What Changes, What Holds
1. Salivary cortisol is still being used mainly as a stress-response readout, but now also as a treatment-response and assay-development target
METHOD Bright-light work keeps salivary cortisol in its established role as a non-invasive marker of HPA-axis and circadian physiology, while the sensor papers shift the emphasis toward how cortisol is measured rather than what cortisol means biologically 41785919Mar42017428Apr. The practical change is that salivary cortisol is increasingly treated as something to monitor continuously or at point of care, but this does not alter the baseline account of its clinical and research utility.
2. Cortisol measurement remains clinically relevant beyond saliva, but these studies do not add new salivary-cortisol biology
REINFORCES The peri-implant and endocrine papers extend the broader importance of cortisol assessment in oral disease, adrenal insufficiency, critical illness, and postoperative care, yet they do not report salivary cortisol results or challenge the baseline description of saliva as a biomarker of HPA activity 42461416Jul42309657Jun. Their main effect is to show continued demand for cortisol-related endocrine readouts, not a new role for salivary cortisol itself.
Overview update candidates: none.
salivary cortisol
Background Contexts
In the literature, the biological baseline, pathological conditions, or disease models commonly surrounding salivary cortisol are described as follows:
- major depressive disorder (Disease) — 2 papers: PMIDs 42461416, 41785919
- music (Other) — 2 papers: PMIDs 42375061, 42085467
- 11β-hydroxylase deficiency (Disease) — 1 paper: PMIDs 42429691
- 17α-hydroxylase/17,20-lyase deficiency (Disease) — 1 paper: PMIDs 38912718
- 3.5GHz (Other) — 1 paper: PMIDs 42244435
- adrenal cortical hypofunction (Other) — 1 paper: PMIDs 42301545
- adrenal crisis (Disease) — 1 paper: PMIDs 42276802
- adrenal insufficiency (Disease) — 1 paper: PMIDs 42276802
- anxiety disorders (Disease) — 1 paper: PMIDs 42461416
- art (Other) — 1 paper: PMIDs 42085467
- Autofluorescence (Other) — 1 paper: PMIDs 42017428
- Brain (Organism) — 1 paper: PMIDs 42244435
Methodologies & Technologies Used
Researchers utilize the following experimental methods, imaging platforms, computational models, or biological reagents to study salivary cortisol:
- high-fat diet (Other) — 2 papers: PMIDs 42385885, 42341055
- (chemo)radiotherapy (Biological Process) — 1 paper: PMIDs 38912718
- 12-lead electrocardiogram (Clinical Metric) — 1 paper: PMIDs 42244435
- 15 days music intervention (Other) — 1 paper: PMIDs 42375061
- adrenocorticotropic hormone stimulation test (Technology) — 1 paper: PMIDs 42301338
- adult female zebrafish (Organism) — 1 paper: PMIDs 42157753
- aerobic exercise (Other) — 1 paper: PMIDs 42157753
- AlphaLisa (Technology) — 1 paper: PMIDs 42467125
- amylase alpha 1C (Protein) — 1 paper: PMIDs 42085467
- anastrozole (Therapy) — 1 paper: PMIDs 42171893
- Beck Depression Inventory (Technology) — 1 paper: PMIDs 42461416
- biomarker enrichment (Other) — 1 paper: PMIDs 42309657
Molecular Interventions & Targets
The primary molecular pathways, regulatory genes, enzymes, or therapeutic agents actively targeted and manipulated in relation to salivary cortisol include:
- autonomic nervous system (Biological Process) — 2 papers: PMIDs 42375061, 42244435
- adrenal insufficiency (Disease) — 1 paper: PMIDs 42301338
- anastrozole (Therapy) — 1 paper: PMIDs 42171893
- anhedonia (Clinical Metric) — 1 paper: PMIDs 41785919
- chromogranin A (Protein) — 1 paper: PMIDs 42467125
- chronic stress-related biomarkers (Other) — 1 paper: PMIDs 42017428
- circadian rhythm disturbances (Clinical Metric) — 1 paper: PMIDs 41785919
- corneal neurotisation surgery (Therapy) — 1 paper: PMIDs 42375061
- cytochrome P450 family 11 subfamily B member 1 (Gene) — 1 paper: PMIDs 42429691
- dehydroepiandrosterone (Chemical) — 1 paper: PMIDs 42461416
- endocrine system (Cellular Component) — 1 paper: PMIDs 42375061
- fludrocortisone (Therapy) — 1 paper: PMIDs 42309657
Observed Outcomes & Phenotypes
The phenotypic changes, physiological endpoints, or clinical metrics observed and measured in connection with salivary cortisol include:
- Adrenocorticotropic hormone (Protein) — 2 papers: PMIDs 42429691, 38912718
- heart rate (Clinical Metric) — 2 papers: PMIDs 42375061, 42244435
- human gut flora (Biological Process) — 2 papers: PMIDs 42341055, 42157753
- (-)-palmitoyl carnitine (Chemical) — 1 paper: PMIDs 42341055
- 1-(11Z-eicosenoyl)-glycero-3-phosphate (Chemical) — 1 paper: PMIDs 42341055
- 17β-estradiol (Chemical) — 1 paper: PMIDs 42171893
- acitretin (Chemical) — 1 paper: PMIDs 42341055
- Acnat2 (Gene) — 1 paper: PMIDs 42341055
- aerobic exercise (Other) — 1 paper: PMIDs 42157753
- amenorrhea (Clinical Metric) — 1 paper: PMIDs 38912718
- amylase alpha 1C (Protein) — 1 paper: PMIDs 42244435
- antioxidant enzyme activities (Biological Process) — 1 paper: PMIDs 42157753
General Takeaways & Clinical Potentials
The high-level concepts, clinical translations, and overarching conclusions proposed in the research surrounding salivary cortisol are summarized below:
- 21 Hydroxylase Deficiency (Disease) — 1 paper: PMIDs 42429691
- aerobic exercise (Other) — 1 paper: PMIDs 42157753
- all-male tilapia production (Other) — 1 paper: PMIDs 42171893
- Bioelectromagnetics (Other) — 1 paper: PMIDs 42244435
- cardiorespiratory endurance (Other) — 1 paper: PMIDs 42375061
- continuous monitoring applications (Other) — 1 paper: PMIDs 42017428
- distress (Clinical Metric) — 1 paper: PMIDs 42461416
- dynamic monitoring of immune biomarkers (Other) — 1 paper: PMIDs 42454331
- elevated stress (Clinical Metric) — 1 paper: PMIDs 42375061
- exposure (Clinical Metric) — 1 paper: PMIDs 42244435
- IL-6/glucocorticoid-SAA1-TLR4 axis (Pathway) — 1 paper: PMIDs 42385885
- Lipophilic grape seed proanthocyanidin (Therapy) — 1 paper: PMIDs 42341055